D.E. Shaw & Co
STAA icon

D.E. Shaw & Co’s STAAR Surgical STAA Stock Holding History

D.E. Shaw & Co’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-29,900
Closed -$1.45M – 4839
2022
Q4 		$1.45M Hold
29,900
– – ﹤0.01% 3186
2022
Q3 		$2.11M Hold
29,900
– – ﹤0.01% 2954
2022
Q2 		$2.12M Hold
29,900
– – ﹤0.01% 3013
2022
Q1 		$2.39M Sell
29,900
-23,000
-43% -$1.71M ﹤0.01% 3138
2021
Q4 		$4.83M Sell
52,900
-46,500
-47% -$4.99M ﹤0.01% 2416
2021
Q3 		$12.8M Buy
99,400
+12,200
+14% +$1.71M 0.01% 1329
2021
Q2 		$13.3M Buy
87,200
+54,200
+164% +$7.14M 0.01% 1273
2021
Q1 		$3.48M Buy
33,000
+23,000
+230% +$2.3M ﹤0.01% 2124
2020
Q4 		$792K Buy
+10,000
New +$732K ﹤0.01% 3176
2019
Q1 		– Sell
-9,800
Closed -$313K – 3905
2018
Q4 		$313K Sell
9,800
-15,800
-62% -$616K ﹤0.01% 3324
2018
Q3 		$1.23M Buy
+25,600
New +$1.05M ﹤0.01% 2549

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
Anatole Investment Management Central, Hong Kong $716M AUM 502.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co's STAA Position: Q1 2026 in Review

D.E. Shaw & Co increased its STAAR Surgical (STAA) stake by 58% in Q1 2026, buying an estimated $195K and bringing the position to 27,846 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #3837.

D.E. Shaw & Co first reported a position in STAA in Q2 2013 and has held it in 35 quarters since. The position peaked at $12.8M in Q2 2018. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • D.E. Shaw & Co held 27,846 shares of STAAR Surgical worth $521K as of Q1 2026.
  • D.E. Shaw & Co bought 10,209 STAAR Surgical shares in Q1 2026, an estimated $195K.
  • STAAR Surgical made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3837 holding.
  • D.E. Shaw & Co first reported a position in STAAR Surgical in Q2 2013 and has held it in 35 quarters since.
  • D.E. Shaw & Co's STAAR Surgical position peaked at $12.8M in Q2 2018.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.